Therapeutic Group: Sodium-glucose Co-transporter 2 inhibitor Presentation EmpatabTM M 5/500: Each tablet contains Empagliflozin INN 5 mg and Metformin Hydrochloride BP 500 mg. Description Empagliflozin (Sodium-glucose co-transporter-2 inhibitor) and Metformin (biguanide) is a combination of two oral antihyperglycemic drugs with complimentary mechanism of action to improve glycemic control in patients with type-2 diabetes mellitus. Empagliflozin […]